IPH.PA

INNATE PHARMA

ParisEUREQUITY DELAYED

1.91

▲ 0.13 (7.30%)

MARKET · —

Price

Open

1.84

Prev close

1.78

Day high

1.94

Day low

1.80

Volume

992.95K

Market cap

—

P/E (TTM)

—

52W range

1.03 – 2.33

Trailing performance

Price return · vs SPY

Returnvs SPY

+2.69% +4.1%

+21.07% +17.3%

+23.10% +20.0%

+35.70% +24.6%

YTD

+19.10% +6.8%

+2.69% -17.3%

-36.82% -111.0%

-71.59% —

Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.

Fundamentals

TTM · reported

Market cap—

Enterprise value—

Revenue (TTM)—

Gross profit—

EBITDA—

Net income—

EPS (TTM)—

Free cash flow—

Total cash—

Total debt—

Book value / share—

Shares outstanding—

Float—

Short % of float—

Dividend yield—

Beta (5Y)—

Valuation & profitability ratios

Account required

Trailing P/E—

Forward P/E—

PEG ratio—

Price / sales—

Price / book—

EV / revenue—

EV / EBITDA—

Gross margin—

Operating margin—

Profit margin—

Return on equity—

Return on assets—

Debt / equity—

Current ratio—

Free account required

Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.

Create free account Sign in

Analyst targets & ownership

Account required

Mean target—

High target—

Low target—

Implied upside—

Analyst count—

Consensus—

Strong buy / Buy— / —

Hold—

Sell / Strong sell— / —

Held by insiders—

Held by institutions—

Institutions holding—

Free account required

Price targets, consensus spread, insider and institutional ownership.

Create free account Sign in

Moving averages & technicals

Computed from 2Y daily closes

SMA 10

1.90

+0.52% from price

SMA 20

1.73

+10.57% from price

SMA 50

1.65

+15.88% from price

SMA 100

1.53

+25.19% from price

SMA 200

1.51

+26.61% from price

EMA 12

1.81

+5.48% from price

EMA 26

1.74

+10.07% from price

EMA 50

1.66

+14.83% from price

RSI (14)

60.0

Neutral

MACD (12,26,9)

0.08

Hist 0.01

ATR (14)

0.17

8.77% of price

Realised vol 30D

88.5%

Annualised

Bollinger upper

2.13

20, 2σ

Bollinger lower

1.32

20, 2σ

50 / 200 cross

Golden

1.65 vs 1.51

Trend bias

Above 200

+26.61%

Risk profile

Daily returns · 1Y window

Beta vs SPY

0.12

Less volatile than market

Correlation to SPY

0.02

Largely independent

Realised vol 30D

88.5%

Annualised

Market vol 1Y

12.9%

SPY, annualised

Max drawdown 1Y

-45.8%

Peak to trough

Max drawdown 5Y

-84.9%

Peak to trough

ATR 14

0.17

8.77% of price

Beta (reported)

—

5Y monthly, from filing

Options chain

Account required

ExpirySpot 1.91

Calls

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Puts

Strike	Last	Bid	Ask	Vol	OI	IV
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%
000.00	0.00	0.00	0.00	0	0	0.0%

Free account required

Every listed expiry, both sides of the book, with volume, open interest and implied volatility.

Create free account Sign in

Headlines

IPH.PA · links out to the publisher

Bear attacks, conflicts with humans reach historic levels in Colorado USA TODAY · 14m ago This Under-the-Radar Healthcare Stock Yields Nearly 8.5%. Here's Whether That Income Is Too Good to Be True. Motley Fool · 14m ago What Would Alan Greenspan Say About This Stock Market? Motley Fool · 14m ago One quantum stock just posted a 9,000% revenue jump TheStreet · 16m ago Lens hammer Auxerre thanks to Thauvin penalty double AFP · 18m ago Outside investigation into St. Paul mayor likely to be costly, with end date unknown Pioneer Press, St. Paul, Minn. · 23m ago Olise helps Bayern past Dortmund in German Supercup AFP · 24m ago Reddit vs. Rigetti Computing: Which High-Growth Stock Is a Better Buy in 2026, the Social Media Giant or Rising Quantum Computing Company? Motley Fool · 25m ago

PRIVATE STRATEGY · BY QUALIFICATION

The same data. A different seat.

The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.